首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   17篇
  免费   1篇
  国内免费   2篇
化学   16篇
晶体学   2篇
物理学   2篇
  2023年   3篇
  2021年   1篇
  2019年   3篇
  2018年   2篇
  2017年   1篇
  2016年   1篇
  2015年   1篇
  2014年   1篇
  2012年   1篇
  2011年   1篇
  2008年   1篇
  2007年   1篇
  2004年   1篇
  2001年   1篇
  1993年   1篇
排序方式: 共有20条查询结果,搜索用时 15 毫秒
1.
The cocrystal of 1,2-bis(diphenylphosphinoyl)ethane (DPPEO) with phenol (1:1) were studied theoretically with AM1, PM3, MNDO and MINDO/3 semi-empirical methods to elucidate its structure. The bond lengths and angles from theoretical studies of molecule DPPEO/phenol (1:1) were found to be as expected. Theoretical results, concerning with intermolecular van der Waals forces in cocrystal, were compared with the previously obtained experimental data and AM1 results were found to be the best fit for bond lengths and angles of DPPEO/phenol.  相似文献   
2.
测定不同温度下阿德福韦酯(AD)在系列浓度糖精(SAC)乙醇溶液中的溶解度及AD在恒温下系列浓度糖精水溶液中的溶解度, 研究AD-SAC共晶形成的热力学, 得到了共晶的溶度积(Ksp)、络合常数(K11)及反应自由能(ΔG0)等热力学参数, 建立了不同温度下的AD-SAC-乙醇三相图. 结果表明: 在乙醇中, 温度对Ksp和K11有极显著性影响(P<0.01), 随着温度的降低, Ksp逐渐减小, K11增大, 共晶的溶解为吸热过程, 共晶的形成为吸热的自发过程, 温度的下降有利于增加AD与SAC在乙醇中的络合效应. AD在SAC水溶液中的溶解度随SAC浓度的升高呈现三阶段特征, 先线性增长至平台区后再倒数下降.  相似文献   
3.
4.
Porous frameworks composed of non-stoichiometrically mixed multicomponent molecules attract much attention from a functional viewpoint. However, their designed preparation and precise structural characterization remain challenging. Herein, we demonstrate that cocrystallization of tetrakis(4-carboxyphenyl)hexahydropyrene and pyrene derivatives ( CP-Hp and CP-Py , respectively) yields non-stoichiometric mixed frameworks through networking via hydrogen bonding. The composition ratio of CP-Hp and CP-Py in the framework was determined by single crystalline X-ray crystallographic analysis, indicating that the mixed frameworks were formed over a wide range of composition ratios. Furthermore, microscopic Raman spectroscopy on the single crystal indicates that the components are not uniformly distributed such as ideal solid solution, but are done gradationally or inhomogeneously.  相似文献   
5.
The 1:1 cocrystal of 2-amino-3-bromopyridine (2A3BP) with 4-methylbenzoic acid (4MBA) has been prepared by slow evaporation method in methanol, which was crystallized in monoclinic P21/c space group having two molecules in the asymmetric unit. The cocrystal has been characterized by single crystal X-ray analysis, FTIR, 1H NMR, 13C NMR, and Powder XRD. Theoretical investigations have been calculated by HF and density function (B3LYP) method with the 6-311+G(d,p) basis set. The vibrational frequencies together with the 1H NMR and 13C NMR chemical shifts have been calculated on the fully optimized geometry of 1. Theoretical calculations of bond parameters, harmonic vibration frequencies, and isotropic chemical shifts are in good agreement with the experimental results. Solvent-free formation of these cocrystal was confirmed by powder X-ray diffraction analysis. The crystal structure was stabilized by Npyridine—H···O = C, C = O—H···Npyridine and C—H···Br hydrogen bonding interactions.  相似文献   
6.
It has been reported that 1,4-diazabicyclo[2,2,2] octane(DABCO) can form complexed crystals with lithium alkals. Our experimental results show that DABCO can also form cocrystals with phenol derivatives such as phenol(2), o-cresol(3), m-cresol(4), p-cresol(5), p-chlorophenol(6), and p-nitrophenol(7). The separa-  相似文献   
7.
烟酰胺, 又称为维生素PP,是辅酶Ⅰ和辅酶Ⅱ的组成部分,是许多脱氢酶的辅酶。庚二酸是一种广泛使用的共晶体前体。烟酰胺与庚二酸形成的药物共晶体具有两种不同的多晶型, 分别为晶型Ⅰ和晶型Ⅱ。不同的药物晶型常常具有不同的物理化学性质,这些差异可能会对药物的溶出速率、稳定性以及药效具有较大影响,因此在药物领域中寻找合适的技术手段鉴别药物的不同晶型非常重要。利用太赫兹时域光谱在室温下对烟酰胺-庚二酸的两种共晶体在0.2~2.2 THz范围内进行检测,发现两者的特征吸收峰具有明显的差异,晶型Ⅰ在1.51,1.73,1.94,2.01和2.17 THz有五个特征吸收峰,其中在1.94,2.01和2.17 THz处是三个吸收强度较大的峰,而晶型Ⅱ在1.66,1.74,1.88,2.02和2.16 THz有五个特征吸收峰,与晶型Ⅰ不同的是在2.02和2.16 THz处有两个强度较大的吸收峰。利用密度泛函理论对烟酰胺-庚二酸两种共晶体进行理论计算,计算结果表明实验峰与理论峰基本对应,对吸收峰指认归属表明特征吸收峰来源于分子骨架的振动与包含氢键的振动。研究结果表明太赫兹时域光谱技术对于区分药物共晶体的多晶型现象具有重要的应用。  相似文献   
8.
In situ crystallization on the diffractometer of 1,1,1,3,3,3‐hexafluoro‐2‐propanol (HFIP) with and without pyridine allows to obtain the new polymorphic form II of HFIP and the cocrystal HFIP‐pyridine. In contrast of the known HFIP form I, single‐crystal X‐ray diffraction analysis of HFIP form II shows a reduced number of molecules in the asymmetric unit (form I: Z′ = 8, form II: Z′ = 4) Furthermore, UNI Force Field calculations were used to gain a deeper understanding of the intermolecular potentials of the main interactions of the described crystal structures.  相似文献   
9.
利用太赫兹时域光谱(THz-TDS)技术在室温下对腺嘌呤、富马酸及两者的共晶体进行测量, 实验结果显示腺嘌呤与富马酸共晶体在0.92、1.24、1.52 THz处有明显的吸收峰, 与腺嘌呤和富马酸不同, 表明共晶体物相结构不同于原料. 根据腺嘌呤分子氢键供体与受体的结构特点, 使用密度泛函理论(DFT)对腺嘌呤与富马酸三种可能的共晶体结构进行模拟. 结果显示其中一种可能的共晶体结构在0.89、1.16、1.41 THz处存在特征吸收峰, 与实验结果较好吻合. 由此判断腺嘌呤与富马酸共晶体氢键形成位置为腺嘌呤的氨基与富马酸其中一个羧酸的碳氧双键形成氢键, 而此羧酸的羟基与腺嘌呤六元环上的邻位氮原子形成第二处氢键. 本文还结合理论模拟的结果对腺嘌呤与富马酸共晶体的特征吸收峰对应的相关振动模式进行了归属.  相似文献   
10.
In recent years, cocrystallization has emerged as an effective way of tuning the properties of compounds and has been widely used in the field of energetic materials. In this study, we have prepared two novel cocrystals of CL‐20 and methylimidazole, including a 1:2 CL‐20 / 2‐mercapto‐1‐methylimidazole ( 1 ) and a 1:4 CL‐20 / 4‐methyl‐5‐nitroimidazole ( 2 ). Cocrystal 1 has good physical and detonation properties (ρ1 = 1.652 g · cm–3, D1 = 7073 m · s–1, P1 = 21.6 GPa); however, cocrystal 2 shows higher properties (ρ2 = 1.680 g · cm–3, D2 = 7945 m · s–1, P2 = 27.4 GPa). The performance of both cocrystals is better than those of TNT. Thermal performance suggests that both the cocrystals have moderate thermal stabilities. Cocrystal 1 decomposes at 164.9 °C and cocrystal 2 has an exothermic peak at 221 °C. Both cocrystals are insensitive energetic explosives (IS > 40 J, FS > 360 N). Methylimidazole compounds are rarely used as coformers to form cocrystals with CL‐20, which possess good properties for a range of potential applications. Herein, we provide new possible directions for enriching cocrystal speciation.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号